Kaya, R. Et Al. 2019. The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases. LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.5 , 592-596.

Kaya, R., Taslimi, P., Naldan, M. E., & GÜLÇİN, İ., (2019). The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases. LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.5, 592-596.

Kaya, Ruya Et Al. "The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases," LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.5, 592-596, 2019

Kaya, Ruya Et Al. "The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases." LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.5, pp.592-596, 2019

Kaya, R. Et Al. (2019) . "The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases." LETTERS IN DRUG DESIGN & DISCOVERY , vol.16, no.5, pp.592-596.

@article{article, author={Ruya Kaya Et Al. }, title={The Impacts of Some Sedative Drugs on alpha -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases}, journal={LETTERS IN DRUG DESIGN & DISCOVERY}, year=2019, pages={592-596} }